Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 195pembrolizumab 158Pemetrexed 136Cisplatin 119durvalumab 73Paclitaxel 72osimertinib 68Nivolumab 66Docetaxel 63Specimen Handling 61atezolizumab 58Magnetic Resonance Spectroscopy 50Etoposide 47Gemcitabine 42Radiotherapy 39Radiosurgery 37130-nm albumin-bound paclitaxel 34Drug Therapy 30Cetuximab 28Bevacizumab 27Ipilimumab 25Taxes 23cemiplimab 22tislelizumab 21Platinum 20Radiation 19amivantamab 18Immunoglobulin G 171,2-diaminocyclohexaneplatinum II citrate 17Disulfides 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Doxycycline × Thoracic × 90 days × Clear all
NCT06120140 2026-06-05

COCOON

Janssen Research & Development, LLC

Phase 2 Active not recruiting
305 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡